496 related articles for article (PubMed ID: 33308173)
1. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
[TBL] [Abstract][Full Text] [Related]
2. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
[TBL] [Abstract][Full Text] [Related]
3. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
[TBL] [Abstract][Full Text] [Related]
4. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
[TBL] [Abstract][Full Text] [Related]
9. Detection of markers predictive of macrolide and fluoroquinolone resistance in
Pitt R; Fifer H; Woodford N; Alexander S
Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
[TBL] [Abstract][Full Text] [Related]
10. Detection of markers predictive of macrolide and fluoroquinolone resistance in
Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R
Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of
Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of
Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
[No Abstract] [Full Text] [Related]
14. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
[No Abstract] [Full Text] [Related]
15. Antimicrobial resistance in
Pitt R; Unemo M; Sonnenberg P; Alexander S; Beddows S; Cole MJ; Clifton S; Mercer CH; Johnson AM; Ison CA; Field N
Sex Transm Infect; 2020 Sep; 96(6):464-468. PubMed ID: 31924741
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST
Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan.
Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M
J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization and Detection of Macrolide and Fluoroquinolone Resistance Determinants in Mycoplasma genitalium in South Africa, 2015 to 2018.
Mahlangu MP; Müller EE; Da Costa Dias B; Venter JME; Kularatne RS
Sex Transm Dis; 2022 Jul; 49(7):511-516. PubMed ID: 35312667
[TBL] [Abstract][Full Text] [Related]
19. A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium.
Plummer EL; Murray GL; Bodiyabadu K; Su J; Garland SM; Bradshaw CS; Read TRH; Tabrizi SN; Danielewski JA
J Microbiol Methods; 2020 Dec; 179():106089. PubMed ID: 33184030
[TBL] [Abstract][Full Text] [Related]
20. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG
J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
